Steris | STE - Operating Expenses


Steris reported $1.27B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
3M USD 3.26B 1.66B Mar/2026
Accuray USD 37.18M 567K Dec/2024
Avanos Medical USD 782.1M 625.97M Mar/2026
Baxter International USD 6.04B 2.85B Mar/2026
Becton, Dickinson and Co. USD 24.13B 19.54B Mar/2026
Boston Scientific USD 4.15B 107M Mar/2026
CONMED USD 291.63M 44.94M Mar/2026
Cooper Companies USD 1.11B 301.2M Mar/2026
Dexcom USD 936.6M 0 Mar/2026
Ecolab USD 3.39B 23M Mar/2026
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
Fortive USD 877.7M 19.3M Mar/2026
Getinge SEK 9.99B 2.3B Dec/2024
Globus Medical USD 595.85M 49.26M Mar/2026
Haemonetics USD 134.99M 1.26M Dec/2025
Idexx Laboratories USD 778.23M 3.26M Mar/2026
Inogen USD 49.14M 665K Sep/2024
Insulet USD 639.7M 2.2M Mar/2026
Integra LifeSciences USD 1.04B 673.49M Mar/2026
Intuitive Surgical USD 1.91B 89.8M Mar/2026
J&J USD 17.44B 1.53B Mar/2026
Masimo USD 326.2M 2.4M Mar/2026
Olympus JPY 268.42B 35.37B Mar/2026
Orthofix International USD 213.79M 12.36M Dec/2025
Owens Minor USD -464.76M 1.17B Mar/2026
ResMed USD 925.74M 525K Mar/2026
Steris USD 1.27B 51.5M Mar/2026
Stryker USD 4.92B 284M Mar/2026
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 3.08B 2.55B Mar/2026
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Zimmer Biomet Holdings USD 1.69B 249.3M Mar/2026